112 related articles for article (PubMed ID: 31661989)
1. Optimizing adjuvant therapies for the treatment of gastric cancer: with a special focus on Asia.
Sasako M
Expert Rev Anticancer Ther; 2019 Nov; 19(11):939-945. PubMed ID: 31661989
[No Abstract] [Full Text] [Related]
2. A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Shi JM; Li N; Jiang LM; Yang L; Wang SL; Song YW; Liu YP; Fang H; Lu NN; Qi SN; Chen B; Li YX; Zhao DB; Tang Y; Jin J
Sci Rep; 2024 Mar; 14(1):7522. PubMed ID: 38553594
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach.
Cellini F; Morganti AG; Di Matteo FM; Mattiucci GC; Valentini V
Radiat Oncol; 2014 Feb; 9():45. PubMed ID: 24499595
[TBL] [Abstract][Full Text] [Related]
4. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract][Full Text] [Related]
5. [Multimodal treatment of locally advanced esophageal adenocarcinoma-Neoadjuvant chemoradiotherapy or perioperative chemotherapy?].
Schröder W; Bruns CJ
Chirurgie (Heidelb); 2024 Jul; 95(7):587-588. PubMed ID: 38839689
[No Abstract] [Full Text] [Related]
6. Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines.
Anker CJ; Dragovic J; Herman JM; Bianchi NA; Goodman KA; Jones WE; Kennedy TJ; Kumar R; Lee P; Russo S; Sharma N; Small W; Suh WW; Tchelebi LT; Jabbour SK
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):186-200. PubMed ID: 32858113
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary management of gastric and gastroesophageal cancers.
Moehler M; Lyros O; Gockel I; Galle PR; Lang H
World J Gastroenterol; 2008 Jun; 14(24):3773-80. PubMed ID: 18609699
[TBL] [Abstract][Full Text] [Related]
8. Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects.
Merrett ND
World J Gastroenterol; 2014 Sep; 20(36):12892-9. PubMed ID: 25278686
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the association between adjuvant chemoradiotherapy and disease-free survival in gastric cancer according to the histology.
Yildirim HC; Guven DC; Akyildiz A; Yalcin S; Dizdar O
Ir J Med Sci; 2023 Dec; 192(6):2631-2634. PubMed ID: 36867373
[TBL] [Abstract][Full Text] [Related]
10. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.
Jung JO; Nienhüser H; Schleussner N; Schmidt T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023907
[TBL] [Abstract][Full Text] [Related]
11. American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma: Systematic Review and Guidelines.
Kumar R; Tchelebi L; Anker CJ; Sharma N; Bianchi NA; Dragovic J; Goodman KA; Herman JM; Jiang Y; Jones WE; Kennedy TJ; Lee P; Kundranda M; Russo S; Small W; Suh WW; Yee N; Jabbour SK
Am J Clin Oncol; 2022 Sep; 45(9):391-402. PubMed ID: 35947781
[TBL] [Abstract][Full Text] [Related]
12. Current and Future Biomarkers in Esophagogastric Adenocarcinoma.
Sappenfield R; Mehlhaff E; Miller D; Ebben JE; Uboha NV
J Gastrointest Cancer; 2024 Jun; 55(2):549-558. PubMed ID: 38280174
[TBL] [Abstract][Full Text] [Related]
13. Palliative care for patients with gastroesophageal cancer at all stages: a narrative review.
DeCarli K; Guyer D; Almhanna K
Ann Palliat Med; 2024 May; 13(3):641-653. PubMed ID: 38600815
[TBL] [Abstract][Full Text] [Related]
14. Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.
Sehdev A; Catenacci DV
J Hematol Oncol; 2013 Sep; 6():66. PubMed ID: 24010946
[TBL] [Abstract][Full Text] [Related]
15. Palliative approach to leptomeningeal carcinomatosis in oesophagogastric junction cancer.
Cunha R; Godinho J; Inácio M; Galriça Neto I
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31604716
[TBL] [Abstract][Full Text] [Related]
16. Best Practices for Managing Patients with Unresectable Metastatic Gastric and Gastroesophageal Junction Cancer in Canada.
Snow S; Gabrielson D; Lim H; Tehfe M; Brezden-Masley C
Curr Oncol; 2024 Apr; 31(5):2552-2565. PubMed ID: 38785472
[TBL] [Abstract][Full Text] [Related]
17. Top advances of the year: Gastroesophageal cancer.
Goodman KA; Hotca A; Liu M; Strong VE; Ilson DH
Cancer; 2024 Jul; 130(13):2253-2256. PubMed ID: 38578983
[No Abstract] [Full Text] [Related]
18. Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.
Luijten JCHBM; Vissers PAJ; Geerts J; Lemmens VEP; van Hillegersberg R; Beerepoot L; Walraven JEW; Curvers W; Voncken FEM; van der Sangen M; Verhoeven RHA; Nieuwenhuijzen GAP
Eur J Surg Oncol; 2023 Sep; 49(9):106880. PubMed ID: 37055281
[TBL] [Abstract][Full Text] [Related]
19. Reoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.
Demeester SR
Gut; 2005 Mar; 54(3):440-1. PubMed ID: 15710999
[No Abstract] [Full Text] [Related]
20. Customization of therapy for gastroesophageal adenocarcinoma patients.
Mizrak Kaya D; Harada K; Amlashi FG; Vasilakopoulou M; Ajani JA
Chronic Dis Transl Med; 2018 Mar; 4(1):8-17. PubMed ID: 29756119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
